unknown
Stage
2
Investors
About
Auron Therapeutics is a clinical-stage biopharmaceutical company developing therapies that target dysregulated cellular differentiation and plasticity to treat oncology and inflammatory diseases.
Explore Auron Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.